Specific interaction with hepatocytes and acute toxicity of new carrier molecule galactosyl-polylysine

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 6, Issue 2, 1999, Pages 127-133

  Shinoda, Tatsuki ^a   Maeda, Atsushi ^a   Kagatani, Seiya ^a   Konno, Yutaka ^a   Goto, Mitsuaki ^b   Sonobe, Takashi ^c   Akaike, Toshihiro ^d  

^a ASTELLAS PHARMA INC   (Japan)

^b Bio Quest Research Co Ltd   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

^d TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Acute toxicity; Adriamycin (Daunorubicin); Asialoglycoprotein receptor; Galactosyl polylysine synthesis; In vitro; Specific interaction; Target to hepatocyte

Indexed keywords

DRUG CARRIER; GALACTOSYL POLYLYSINE POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIODEGRADATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG LIVER LEVEL; DRUG TARGETING; DRUG TRANSPORT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; STRUCTURE ANALYSIS; TISSUE SPECIFICITY;

EID: 0033003833     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/107175499267057     Document Type: Article

References (27)

1. Akaike, T., M. Goto, A. Maeda, and T. Shinoda. 1993. A galactopyranosyl-substituted poly-ε-L-lysine. Japan patent 236790, 22 September.
2. Connors, T. A., R. Duncan, and R. J. Knox. 1995. The chemotherapy of colon cancer. Eur. J. Cancer 31:1373-1378.
3. Dragsten, P. R., D. B. Mitchell, G. Covert, and T. Baker. 1987. Drug delivery using vesicles targeted to the hepatic asialoglycoprotein receptor. Biochim. Biophys. Acta 926:270-279.
4. Duncan, R., R. P. Kopeckova, J. Strohalm, I. Hume, H. C. Cable, J. Pohl, J. B. Lloyd, and J. Kopecek. 1987. Anticancer agents coupled to N-(2-hydroxypropyl) methacrylamide copolymers, I. Evaluation of daunomycin and puromycin conjugates in vitro. Br. J. Cancer 55:165-174.
5. Duncan, R., P. Kopeckova, J. Strohalm, I. C. Hume, J. B. Lloyd, and J. Kopecek. 1988. Anticancer agents coupled to N-(2-hydroxypropyl) methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukemia. Br. J. Cancer 55:147-156.
6. Duncan, R., L. W. Seymour, K. B. O'Hare, P. A. Flanagan, S. Wedge, I. C. Hume, K. Ulbrich, J. Strohalm, V. Subr, F. Spreafico, M. Grandi, M. Ripamonti, M. Farao, and A. Suarato. 1992. Preclinical evaluation of polymer-bound doxorubicin. J. Control. Release 19:331-346.
7. Fujita, T., M. Nishikawa, C. Tamaki, Y. Takakura, M. Hashida, and H. Sezaki. 1992. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. J. Pharmacol. Exp. Ther. 263:971-978.
8. 125I-labelled lactose-carrying polystyrene. J. Control. Release 28:223-233.
9. Hashida, M., R. Atumi, K. Nishida, S. Nakane, Y. Takakura, and H. Sezaki. 1990. Biliary Excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran. J. Pharmacobio-Dyn. 13:441-447.
10. Hirabayashi, H., M. Nishikawa, Y. Takakura, and M. Hashida. 1996. Development and pharmacokinetics of galactosylated poly-l-glutamic acid as a biodegradable carriers for liver-specific drug delivery. Pharm. Res. 13:880-884.
11. Kollen, W. J. W., P. Midoux, P. Erbacher, A. Yip, A. C. Roche, M. Monsigny, M. C. Glick, and T. F. Scanlin. 1996. Gluconoylated and glycosylated polylysines as vectors for gene transfer into cystic fibrosis airway epithelial cells. Hum. Gene Ther. 7:1577-1586.
12. Mahato, R. I., S. Takemura, K. Akamatsu, M. Nishikawa, Y. Takakura, and M. Hashida. 1997. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly (l-lysine). Biochem. Phannacol. 53:887-895.
13. Midoux, P., C. Mendes, A. Legrand, J. Raimond, R. Mayer, M. Monsigny, and A. C. Roche. 1993. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res. 21:871-878.
14. Nishikawa, M., Y. Ohtsubo, J. Ohno, T. Fujita, Y. Koyama, F. Yamashita, M. Hashida, and H. Sezaki. 1992a. Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice. Int. J. Pharm. 85:75-85.
15. Nishikawa, M., F. Yamashita, Y. Takakura, M. Hashida, and H. Sezaki. 1992b. Demonstration of the receptor-mediated hepatic uptake of dextran in mice. J. Pharm. Pharmacol. 44:396-401.
16. Nishikawa, M., H. Hirabayashi, Y. Takakura, and M. Hashida. 1995. Design for cell-specific targeting of protein utilizing sugar-recognition mechanism: Effect of molecular weight of proteins on targeting efficiency. Pharm. Res. 12:209-214.
17. Ogawara, K., M. Nishikawa, Y. Takakura, and M. Hashida. 1998. Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver. J. Control. Release 50:309-317.
18. Oka, A., M. D. Christensen, and P. H. Weigel. 1989. Hyperosmolarity inhibits galactosyl receptor-mediated but not fluid phase endocytosis in isolated rat hepatocytes. J. Biol. Chem. 264:12016-12024.
19. Rohlff, C., G. Holt, S. Courtney, and J. Trepel. 1997. Enhanced liver specific activity of a glycan-conjugated 5-FU for the treatment of hepatocellular cancer. Proc. Am. Assoc. Cancer Res. 38:104.
20. Seglen, P. O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83.
21. Shinoda, T., A. Maeda, S. Kagatani, Y. Konno, M. Goto, T. Sonobe, and T. Akaike. 1998. Specific interaction with hepatocytes, acute toxicity and drug release of new carrier molecule galactosyl-poly-glutamate. J. Control. Release.
22. Takakura, Y., T. Fujita, H. Furitsu, M. Nishikawa, H. Sezaki, and M. Hashida. 1994. Pharmacokinetics of succinylated proteins and dextran sulfate in mice: Implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors. Int. J. Pharm. 105:19-29.
23. Takakura, Y., T. Fujita, M. Hashida, and H. Sezaki. 1990. Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 7:339-346.
24. Toyama, H., K. Ito, Y. Komori, A. Sugioka, K. Shibata, S. Komai, T. Fujiwara, E. Ishikawa, K. Tomita, and N. Fujii. 1995. Evaluation of the residual functional reserve and the early regeneration after the hepatic resection using asialoglycoprotein receptor imaging agent. Kaku Igaku 32:323-329.
25. Trouet, A., M. Masquelier, R. Baurain, and D. C. D. Deprez. 1982. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: In vitro and in vivo studies. Proc. Natl. Acad. Sci. USA 79:626-629.
26. Williamson, J., F. T. J. Scott, M. A. Hardman, and J. R. Brown. 1981. Try-panocidal activity of daunorubicin and related compounds. Nature 292:466-467.
27. Wu, G. Y., and C. H. Wu. 1987. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262:4429-4432.